Pulmonx CorporationPulmonx CorporationPulmonx Corporation

Pulmonx Corporation

No trades
See on Supercharts
Market capitalization
‪286.33 M‬USD
−1.60USD
‪−60.84 M‬USD
‪68.68 M‬USD
‪34.95 M‬
Beta (1Y)
1.45

About Pulmonx Corporation

CEO
Steven S. Williamson
Headquarters
Redwood City
Employees (FY)
279
Founded
1995
ISIN
US7458481014
FIGI
BBG000LZVJC9
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LUNG is 7.43 USD — it has increased by 0.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pulmonx Corporation stocks are traded under the ticker LUNG.
Pulmonx Corporation is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Pulmonx Corporation has a max estimate of 20.00 USD and a min estimate of 14.00 USD.
LUNG earnings for the last quarter are −0.39 USD whereas the estimation was −0.43 USD which accounts for 8.86% surprise. Estimated earnings for the next quarter are −0.41 USD. See more details about Pulmonx Corporation earnings.
Pulmonx Corporation revenue for the last quarter amounts to ‪17.67 M‬ USD despite the estimated figure of ‪16.67 M‬ USD. In the next quarter revenue is expected to reach ‪18.24 M‬ USD.
Yes, you can track Pulmonx Corporation financials in yearly and quarterly reports right on TradingView.
LUNG stock has fallen by 11.23% compared to the previous week, the month change is a 18.71% fall, over the last year Pulmonx Corporation has showed a 36.00% decrease.
Like other stocks, LUNG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pulmonx Corporation stock right from TradingView charts — choose your broker and connect to your account.
LUNG reached its all-time high on Dec 31, 2020 with the price of 69.48 USD, and its all-time low was 4.07 USD and was reached on Nov 4, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 279.00 employees. See our rating of the largest employees — is Pulmonx Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pulmonx Corporation EBITDA is ‪−58.96 M‬ USD, and current EBITDA margin is −87.35%. See more stats in Pulmonx Corporation financial statements.